Matches in DBpedia 2016-04 for { ?s ?p "'Chugai Pharmaceutical Co., Ltd. (Mong yung Biep-Chūgai Seiyaku Kabushikigaisha) is a subsidiary drug manufacturer operating in Japan controlled by Hoffmann–La Roche, which owns 62% of the company as of 30 June 2014. Previous to Roche's takeover in 2002, Chugai was a pioneering discoverer of many important pharmaceutical compounds. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director, chairman, and CEO. Tatsuro Kosaka is the current representative director, president, and COO."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Chugai_Pharmaceutical_Co. abstract "'Chugai Pharmaceutical Co., Ltd. (Mong yung Biep-Chūgai Seiyaku Kabushikigaisha) is a subsidiary drug manufacturer operating in Japan controlled by Hoffmann–La Roche, which owns 62% of the company as of 30 June 2014. Previous to Roche's takeover in 2002, Chugai was a pioneering discoverer of many important pharmaceutical compounds. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director, chairman, and CEO. Tatsuro Kosaka is the current representative director, president, and COO.".
- Q750619 abstract "'Chugai Pharmaceutical Co., Ltd. (Mong yung Biep-Chūgai Seiyaku Kabushikigaisha) is a subsidiary drug manufacturer operating in Japan controlled by Hoffmann–La Roche, which owns 62% of the company as of 30 June 2014. Previous to Roche's takeover in 2002, Chugai was a pioneering discoverer of many important pharmaceutical compounds. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director, chairman, and CEO. Tatsuro Kosaka is the current representative director, president, and COO.".